by Caitlin Kingsley | Dec 1, 2014 | Genetic Journal
It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop breast cancer (50-85% lifetime risk) and ovarian cancer (15-60% lifetime risk). Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test...
by Caitlin Kingsley | Nov 18, 2014 | Genetic Journal
This week JAMA published a viewpoint on whether life insurers should have access to genetic test results and, understandably, it unearthed some long-standing fears about genetic discrimination. We do have protection from some forms of such discrimination under the...
by Caitlin Kingsley | Nov 11, 2014 | Genetic Journal
Internet giant Google announced last week that it will cover the cost of genetic tumor profiling for their employees (and their family members) who develop cancer. This type of genetic testing for cancer treatment, often called precision or personalized medicine,...